Mesh.i
Exploration
Accueil
Racine
Exploration
Accueil
Racine

La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « Mesh.i » - entrée « Nervous System Diseases »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Nervous System < Nervous System Diseases < Nervous System Neoplasms  Facettes :

List of bibliographic references indexed by Nervous System Diseases

Number of relevant bibliographic references: 20.
Ident.Authors (with country if any)Title
000187 (2016) Gerald W. Zamponi [Canada]Targeting voltage-gated calcium channels in neurological and psychiatric diseases.
000391 (2016) Philippe Finès [Canada] ; Rochelle Garner [Canada] ; Christina Bancej [Canada] ; Julie Bernier [Canada] ; Douglas G. ManuelDevelopment and implementation of microsimulation models of neurological conditions.
000493 (2015) Marcus W. Koch [Canada] ; Lawrence Korngut [Canada] ; David G. Patry [Canada] ; Yahya Agha-Khani [Canada] ; Christopher White [Canada] ; Justyna R. Sarna [Canada] ; Michael Yeung [Canada] ; V Wee Yong [Canada] ; Daniel Y C. Heng [Canada] ; Gary Cutter [États-Unis] ; Luanne Metz [Canada]The promise of futility trials in neurological diseases.
000841 (2015) John C. Steele ; Robert Wresch [États-Unis] ; Samuel D. Hanlon [États-Unis] ; Jay Keystone [Canada] ; Yoav Ben-Shlomo [Royaume-Uni]A unique retinal epitheliopathy is associated with amyotrophic lateral sclerosis/Parkinsonism-Dementia complex of Guam.
000963 (2014) Oana Danila [Canada] ; John P. Hirdes [Canada] ; Colleen J. Maxwell [Canada] ; Ruth Ann Marrie [Canada] ; Scott Patten [Canada] ; Tamara Pringsheim [Canada] ; Nathalie Jetté [Canada]Prevalence of neurological conditions across the continuum of care based on interRAI assessments
000A74 (2014) Michelle Ploughman [Canada] ; Jennifer Shears [Canada] ; Chelsea Harris [Canada] ; Stephen H. Hogan [Canada] ; Olivia Drodge [Canada] ; Sherry Squires [Canada] ; Jason Mccarthy [Canada]Effectiveness of a novel community exercise transition program for people with moderate to severe neurological disabilities.
000A95 (2014) Erin L. Heinzen [États-Unis] ; Alexis Arzimanoglou [France] ; Allison Brashear [États-Unis] ; Steven J. Clapcote [Royaume-Uni] ; Fiorella Gurrieri [Italie] ; David B. Goldstein [États-Unis] ; Sigur Ur H. J Hannesson [Islande] ; Mohamad A. Mikati [États-Unis] ; Brian Neville [Royaume-Uni] ; Sophie Nicole [France] ; Laurie J. Ozelius [États-Unis] ; Hanne Poulsen [Danemark] ; Tsveta Schyns [Belgique] ; Kathleen J. Sweadner [États-Unis] ; Arn Van Den Maagdenberg [Pays-Bas] ; Bente Vilsen [Danemark]Distinct neurological disorders with ATP1A3 mutations.
000D37 (2013) Danielle Murray [Canada] ; A Jon StoesslMechanisms and therapeutic implications of the placebo effect in neurological and psychiatric conditions.
001499 (2012) Christine St. Germaine-Smith [Canada] ; Amy Metcalfe [Canada] ; Tamara Pringsheim [Canada] ; Jodie Irene Roberts [Canada] ; Cynthia A. Beck [Canada] ; Brenda R. Hemmelgarn [Canada] ; Jane Mcchesney [Canada] ; Hude Quan [Canada] ; Nathalie Jette [Canada]Recommendations for optimal ICD codes to study neurologic conditions: A systematic review
001659 (2011) Connie Marras [Canada] ; Samuel M. GoldmanGenetics meets environment: evaluating gene-environment interactions in neurologic diseases.
001A30 (2010) V. Wee Yong [Canada]Inflammation in neurological disorders: a help or a hindrance?
001A68 (2010) C. Hamani [Canada] ; J N Nobrega ; A M LozanoDeep brain stimulation in clinical practice and in animal models.
001A75 (2010) Walter Glannon [Canada]Consent to deep brain stimulation for neurological and psychiatric disorders.
003624 (1999) K. Kumar [Canada] ; M. Kelly ; C. TothDeep brain stimulation of the ventral intermediate nucleus of the thalamus for control of tremors in Parkinson's disease and essential tremor.
004157 (1994) M. D. Berry [Canada] ; A. V. Juorio [Canada] ; I. A. Paterson [Canada]Possible mechanisms of action of (−)deprenyl and other MAO-B inhibitors in some neurologic and psychiatric disorders
004298 (1994) D. B. Calne [Canada] ; N.-S. Chu ; C.-C. Huang ; C.-S. Lu ; W. OlanowManganism and idiopathic parkinsonism : similarities and differences
004450 (1993) A. Beuter [Canada] ; J. Belair ; C. LabrieFeedback and delays in neurological diseases: a modeling study using dynamical systems
005583 (????) Sarah C Christine Lidstone [Canada] ; A Jon StoesslUnderstanding the placebo effect: contributions from neuroimaging.
005620 (????) Alonso Montoya [Canada] ; Bruce H. Price ; Martin LepageNeural correlates of 'functional' symptoms in neurology.
005624 (????) P K Pal [Canada] ; A. Samii ; D B CalneManganese neurotoxicity: a review of clinical features, imaging and pathology.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Nervous System Diseases" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Nervous System Diseases" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Nervous System Diseases
}}
Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022